FDA Whistleblower Claims the FDA is Not Properly Inspecting Plants where Vaccines are Manufactured, Mainly Merck Who Will Begin Producing COVID Experimental Vaccines

After it was recently announced that Merck & Co. would take over producing some of the experimental COVID "vaccines" for Johnson and Johnson, an FDA whistleblower has now stepped forward to reveal that the FDA is not properly examining production facilities where these experimental COVID shots are being produced. This is just another routine incident that highlights the incestuous relationship between Big Pharma and government health regulatory agencies like the FDA and the CDC, which primarily work for the pharmaceutical industry to maximize their profits, and are not very concerned about public health at all. Most of the people appointed to these government agencies come out of the pharmaceutical industry, and then return there once they are finished working for agencies like the FDA and the CDC. Merck is now set to join the ranks of pharmaceutical companies producing experimental COVID injections that have a long history of criminal activity. We have previously reported how Pfizer is notorious for previously having the largest criminal settlement with the Department of Justice, and Johnson and Johnson also has a very long criminal rap sheet ranging from their baby powder causing cancer, to flawed hip replacements and multiple product recalls that have harmed millions. So now faced with manufacturing problems in producing enough of the experimental COVID injections, they are turning to another criminal organization to help them, Merck. Merck's vaccines historically have probably killed and maimed more people than any other vaccine manufacturer, and they are still embroiled in lawsuits to this day over some of their vaccines, mainly the measles, mumps, and rubella (MMR) vaccine, and their HPV vaccine, Gardasil. And now they are slated to use a plant to help produce the Johnson and Johnson experimental COVID shots, where employees are deliberately soiling their clothes with blood, urine and feces because they don't want to take the time to use the restrooms and go through the entire sterilization process again, and the FDA is overlooking this. And yet the vast majority of the public remains religiously pro-vaccine and are rushing out to get experimental injections produced by criminal pharmaceutical companies and regulated by criminal government regulatory agencies that are supposed to be overseeing them. The reduction of the world's population is in full swing now, and the pro-vaccine masses are the first ones to be culled.

Has the Merck Pharmaceutical Company Killed More People than the U.S. Military or Any Terrorist Organization?

Which private corporation has likely been responsible for the deaths of more innocent people than any terrorist organization or military regime change in Afghanistan, Iraq, Libya, Syria and elsewhere? For us, the answer is evident: Merck and Company. One of the largest scandals in recent medical history was the company's anti-inflammatory drug Vioxx that resulted in fines above $4.8 billion for causing over a minimum 60,000 deaths from sudden heart attacks and over 120,000 serious medical injuries. At its height, Vioxx was earning over $2 billion in revenues annually and it is estimated that 25 million patients were prescribed the medication. The securities class action suit against the company alone reached $1 billion, placing it in the top 15 securities lawsuits in US corporate history. The primary charge was Merck's intentional withholding of scientific data about the drug's adverse cardiovascular side effects.  Years after the settlement, Ron Unz, the publisher of The American Conservative, undertook his own investigation to validate Vioxx's death toll. Analyzing the drug's adverse effects over a longer time period, Unz estimated Merck may have been responsible for nearly half a million premature deaths in elderly patients, the drug's primary target group. That is roughly the same number of total civilian, military and terrorist deaths from the US' military escapades in Afghanistan, Iraq and Pakistan combined.  Merck is America's leading vaccine manufacturer. What is important at this moment is that many corporations are fast-tracking a Covid-19 vaccine, without sufficient long-term animal and human clinical trials, and Merck is now aggressively making efforts to beat out its competition with a Covid-19 vaccine. Do we really want to trust such a company with this reputation with a Covid vaccine?

Not Wanting to Get Left Behind, Merck Nabs $38 MILLION from U.S. Government to Develop COVID Vaccine

Despite the fact that they are currently embattled in two federal lawsuits for fraud regarding the development of their MMR and Gardasil vaccines, Merck jumped into the COVID-19 race and nabbed $38 MILLION of American taxpayer funds to develop COVID products, including vaccines, it was announced today. The transfer of American wealth to the criminal pharmaceutical industry continues as millions are out of work and non-pharmaceutical businesses go bankrupt.

Former CDC Head and Merck’s Current Vaccine Division President Julie Gerberding Sells $9.1 Million in Merck Pharmaceutical Shares as Gardasil Vaccine Gets Bad Press

SEC filings reveal that Merck’s Vaccine Division President Julie Gerberding sold over half her Merck shares in January for $9.1 Million. That transaction followed a spate of bad news for Merck’s flagship Gardasil vaccine. Last month, Cancer Research UK announced an alarming 54% rise in cervical cancer among 24-29-year-olds, the first generation to receive the HPV jabs. The following day, the Journal of the Royal Society of Medicine published a withering critique of Gardasil’s crooked clinical trials, “It is still uncertain whether human papillomavirus (HPV) vaccination prevents cervical cancer as trials were not designed to detect this outcome.” As Gerberding knows, those trials revealed that Gardasil dramatically RAISES (by+44.6%) the risk of cervical cancer among women with a current infection or those previously exposed to HPV. Merck is now fighting existential fraud lawsuits on both the MMR and Gardasil vaccines, that threaten licensing for those key products. Fat rats are always the first to jump ship.

Is Merck’s 9-Year Long Whistleblower Fraud Lawsuit on the MMR Vaccine Finally Coming to a Resolution?

With all the "measles outbreaks" that brought national headlines earlier this year, and resulted in may states introducing legislation to force vaccinate the public and remove vaccine exemptions for school-age children, one thing the national corporate-sponsored "mainstream" media failed to report, is that the only vaccine available in the U.S. for measles has been involved in an 9-year long legal battle for fraud, due to Merck's own scientists who helped develop the vaccine becoming whistleblowers. First of all, there is no measles vaccine available in the U.S., only a 3 dose combination vaccine for mumps, measles and rubella (MMR), which is licensed to Merck. The mumps portion of the vaccine is what Merck's own scientists have claimed is fraudulent, and not effective. The only time the corporate media, which is heavily funded by the pharmaceutical industry, really covered the lawsuit was two years after it was originally filed back in 2010, when in 2012 a judge unsealed key documents. It is not surprising then that the CDC and other government health agencies are concentrating on cases of measles in the U.S. public, instead of outbreaks of mumps which far exceeds measles outbreaks, and happens primarily among the vaccinated population. Health Impact News has been following the Merck MMR fraud lawsuit for over 6 years now, and we exposed the hypocrisy of government health officials concentrating on measles outbreaks, even though mumps outbreaks are far more serious, earlier this year. Attorney Robert F. Kennedy, Jr. is now reporting that the 9-year-old long MMR fraud lawsuit may be coming to an end, and that U.S. Department of Health and Human Services officials are trying to get the FDA to approve the Glaxo Smith Kline (GSK) version of the MMR vaccine in the U.S. in case the judge rules against Merck. However, there is no evidence that GSK's version of the vaccine is any better.

Judge Protects Merck Pharmaceutical Company Instead of the Public by Allowing Merck to Hide Side Effects of FDA Approved Drugs

A Reuters investigative report reveals how Federal judges are complicit in shielding pharmaceutical giants like Merck & Co. by allowing the company to conceal the evidence of real risks of harm from widely prescribed drugs. The risks are concealed from physicians and the public. “It goes without saying that the more information a physician has, the more he can share with the patient and the more informed the decision-making process becomes.” —  Nelson Novick, MD Merck’s Corporate Rap Sheet includes court adjudicated lawsuit findings against the company which has paid multi-billion dollars in settlements for False Claims, Product Safety/Concealment of serious adverse effects, Bribery, Tax fraud, and more. Multiple Merck products caused severe harm, including deaths; these include: the arthritis drug Indocin®  (1960s); the widely prescribed drug for pregnant women, diethylstilbestrol (DES)®  drug that caused women vaginal cancer (1970s); Vioxx®, the painkiller prescribed for arthritis (1999-2004) caused, 140,000 heart attacks and an estimated30 to 60,000 deaths. Merck paid $4.85 Billion to settle Vioxx lawsuits.  Another controversial drug is Fosamax®  prescribed for osteoporosis (1990s) which causes osteonecrosis of the jaw and thighbone fractures; Januvia® , linked to pancreatitis, pancreatic cancer, and severe joint pain. A Reuters investigative reporter Dan Evine, reveals how Judge Brian Cogan – who sat in judgment over 900 Propecia®  lawsuits in New York federal court – enabled Merck to conceal the documents that proved the company’s culpability.

Merck Continues to Make Hundreds of Millions on Measles Vaccine – 58% Increase After 2019 Measles “Outbreak”

Sales of Merck's measles vaccine, the MMR combo vaccine that also includes mumps and rubella, continues to soar as Merck reported this week that in the second quarter of 2019, sales for the measles vaccine were 58% higher than the year before, at $675 million. As CNBC reports: "Pharmaceutical giant Merck said Tuesday that high consumer demand for its measles vaccines, amid the largest U.S. outbreak in decades, helped boost sales in its second quarter. Sales of children’s vaccines, which includes the New Jersey-based company’s MMR vaccine, for measles, mumps and rubella, jumped 58% year over year to $675 million, Merck announced in its second-quarter earnings report Tuesday. Merck, which is the sole U.S. supplier of measles vaccines, said the strong growth was due in part to this year’s measles outbreak..." Is there any other sector of the U.S. economy that is more profitable than vaccines? Consider these facts: 1. The U.S. Government gave legal immunity to pharmaceutical companies in 1986, because Big Pharma threatened Congress by stating they would stop manufacturing and selling vaccines due to the many lawsuits brought against them for vaccine injuries. Vaccines have proliferated in the market place since 1986 as a result, with the CDC recommending up to 69 doses of vaccines to children before they reach the age of 18. 2. In most states, the CDC recommended vaccine schedule is required for children at attend school. 3. The U.S. Government owns several patents on vaccines, and the CDC is the largest purchaser of vaccines, using U.S. taxpayer funds to purchase more than $5 billion in vaccines each year. Is there any other market in the U.S. where there is virtually no liability for your products, the government requires you to purchase the product, and the government itself is the largest customer of those products? Also, most vaccines have only one manufacturer approved by the U.S. government for sale in the U.S., such as the MMR vaccine, creating a monopoly for that product. And if that is not enough to ensure business success, local health departments can pick and choose which illnesses should be classified as "outbreaks" which are then announced by the compliant corporate media, largely funded by the pharmaceutical industry, to boost sales of a vaccine even more.

Gardasil Vaccine on Trial: Attorney Robert F. Kennedy, Jr. Exposes Merck Corruption

Robert F. Kennedy, Jr. is one of the attorneys in the Jennifer Robi vs. Merck and Kaiser Permanente fraud case currently being litigated in Los Angeles Superior Court. This must-watch video, referencing much of the science presented as evidence during the trial, details the many problems with the development and safety of Merck’s third-highest grossing product, Gardasil. Children’s Health Defense (CHD) and Robert F. Kennedy, Jr., CHD’s Chairman and Chief Legal Counsel, ask that you watch and share this video so that you, and others, may make an informed decision of whether or not to give your child, boy or girl, a Gardasil vaccine. It can also be a useful tool for pediatricians who are trying to understand how this vaccine, that is actually causing health problems with young people, could have been approved by FDA and then recommended by CDC. The video is full of jaw-dropping facts about Gardasil and the clinical trials leading up to its release upon an unsuspecting public.

Merck Profits Soar As MMR Measles Vaccine Increases 27% to $496 Million in 2019

There is nothing like a good "measles outbreak" to boost sales when you have a monopoly on the only measles vaccine available, and corporate-funded mainstream media does almost all of your marketing for free, by singing the praises of the vaccine while never mentioning potential side effects or criminal cases currently in place over corruption surrounding the development of the vaccine. Given the fact that U.S. law prevents anyone from suing Merck if a vaccine injury or death occurs from their vaccines, and that the U.S. Government via the CDC is the largest purchaser of vaccines to the tune of $5 billion per year, the vaccine industry has become perhaps the most lucrative market in the history of the world. Merck & Co Inc. reported higher-than-expected first-quarter profits for 2019. Sales of the MMR measles vaccine soared to 27% to $496 million. The company also saw strong sales growth overseas for its Gardasil vaccine, as sales rose 27 percent to $828 million, beating analyst expectations by about $25 million.

Nation’s Leading Lawyers take on Gardasil Vaccine Fraud in U.S. Court

It was truly a red-letter day. Jennifer’s lawyers brilliantly laid bare Merck’s anemic case for Gardasil, dissecting the science in withering presentations challenging both the efficacy and safety of the Gardasil vaccine, and then chronicling the horrifying agency and corporate corruption that lead to its approval. Jennifer Robi is a 24-year-old former athlete and scholar who has been confined to a wheelchair since receiving her third Gardasil vaccines at age sixteen. She suffers continual uncontrolled neuro/muscular contractions (jerking) and postural orthostatic tachycardia syndrome (POTS) and many other symptoms of systemic autoimmune dysregulation. Jennifer’s attorney, Sol Ajalat, initially brought her case in Vaccine Injury Compensation Program and then, following a judgment in the program, elected to proceed in civil court. Since VICA (the Vaccine Injury Compensation Act) forbids recoveries for product defect or negligence, Ajalat brought Jennifer’s civil case under the theories that Merck committed fraud during its clinical trials and then failed to warn Jennifer (and, by implication, other injured girls) about the high risks and meager benefits of the vaccine. In order to support Sol Ajalat and his sons Greg, Larry, and Steve, who compose the Los Angeles firm Ajalat & Ajalat, a blue ribbon A-Team of the nation’s leading plaintiffs’ law firms have joined Jennifer’s trial team. These include the firms most feared by Pharma: Weitz & Luxenberg (countless major pieces of litigation over 30 years), Morgan & Morgan (Vioxx, Phenphen, Breast Implants, Tobacco), Baum Hedlund, (Monsanto $289 million verdict 2018 and the $54 million 2000 verdict against Bayer in Haemophiliac/AIDS case) as well as Children’s Health Defense’s own Robert F. Kennedy, Jr. and Kim Mack Rosenberg (a co-author of The HPV on Trial).

Merck’s Hepatitis B Vaccine Shortage Linked to Reduced Deaths In Babies

In the summer of 2017, a malware virus mainly affecting the Ukraine, found its way onto the mainframe computer systems of Merck wreaking havoc for the company. According to the Wall Street Journal, the incident cost the pharmaceutical giant $670 million to remediate, but more importantly, it caused disruption to the production of two of Merck’s pediatric vaccines: Gardasil 9 (Human Papillomavirus) and Recombivax (Hepatitis B virus), vaccines to help prevent sexually transmitted infections. During the crisis, Merck borrowed from a CDC vaccine stockpile, in order to meet supply commitments for Gardasil 9. However, that was not the case with Recombivax, the Hepatitis B vaccine given to all babies beginning the first day of life. There is growing concern among some scientists about the aluminum adjuvant load in vaccines and its effects on the neurological health of children. Researchers are particularly concerned with Merck’s highly immunogenic adjuvant, Amorphous Aluminum Hydroxyphosphate Sulphate (AAHS). Gardasil and Recombivax are the only vaccines licensed to contain AAHS. We now have more than a year’s worth of data to examine since the attack in 2017 when Engerix-B was introduced. On average there were 29 deaths reported annually for fifteen years prior to the attack (2003 to 2017). In 2018 there were only 6 reported (to end of November 2018). Two of those deaths followed Recombivax.

‘Unprecedented’ Sales for Merck’s Gardasil Vaccine as They Seek World Domination for HPV Vaccines

Merck's Gardasil vaccine saw a 55% increase over last year’s third quarter, netting $1.05 billion in global sales for the third quarter of 2018. Thanks to worldwide sales, the Gardasil vaccine has become the top money maker for Merck. FiercePharma, the marketing trade publication for vaccine manufacturers, reports that Merck’s Gardasil has been propelling the pharma giant’s vaccine unit in recent quarters, and that doesn't look like it'll be changing. The company sees more growth ahead thanks to an “unprecedented increase in worldwide demand” for HPV vaccines, an executive said. Addressing the vaccine's performance on a recent conference call, Merck’s president of global human health Adam Schechter said the company is “seeing unprecedented increase in worldwide demand for the HPV vaccines.” He said global demand has “doubled in the last year alone.” Meanwhile, the carnage left behind from mass Gardasil vaccination programs continues to get world-wide exposure, as doctors, scientists, and victims look for ways to oppose mass Gardasil vaccination programs. A recent gathering in Ireland at an IFICA conference brought together many world leaders to discuss the Gardasil problem, and another meeting is scheduled in the U.S. in 2019 during the Autism One conference, at the 4th Annual International HPV Vaccine Education Symposium.

Lawfirm Announces $101 Million Measles Vaccine Settlement for Infant that Suffered Brain Injury

The lawfirm of Maglio Christopher & Toale, P.A. announced earlier this month (July, 2018) that they had negotiated a $101 million dollar settlement for an infant who suffered a severe reaction to the Measles Mumps Rubella (MMR) vaccine. A one-year-old healthy baby girl, who was already walking and climbing, received vaccinations for Measles Mumps Rubella (MMR), Hepatitis A, Haemophilus Influenzae type B (Hib), Prevnar (pneumonia), and Varicella (chickenpox) on February 13, 2013. That evening, the mother noticed the baby was irritable and feverish. After a call to the pediatrician, the doctor advised Mom to give her Tylenol and Benadryl. The fever continued for several days, and on the evening before the baby’s scheduled pediatrician visit, the baby began having severe seizures. She was rushed to the emergency room. She went into cardiac and respiratory arrest, and doctors placed her on a ventilator. The seizures and cardiac arrest left the baby with a severe brain injury, encephalopathy, cortical vision impairment, truncal hypotonia (low muscle tone), and kidney failure. After months of treatment at the hospital, the baby finally went home, but her disabilities required specialized medical care and supervision around the clock for the rest of her life. The $101 million dollar settlement will pay for the child’s constant high-level medical care for the rest of her life. The family received a lump sum of $1 million dollars to cover the immediate costs of medical bills and expenses. The rest will be paid out through an annuity over the child’s lifetime. Don't expect to read this story in the Big Pharma-sponsored corporate "mainstream" media, where the official doctrine is that vaccines are "safe and effective."

Merck Receives FDA Priority Review to Expand Dangerous Gardasil Vaccine to Women and Men Ages 27 to 45

Gardasil vaccine manufacturer, Merck, announced earlier this month (June, 2018) that the U.S. Food and Drug Administration (FDA) has granted them a "Priority Review" to approve the dangerous and controversial Gardasil 9 vaccine to women and men, ages 27 to 45. The Gardasil vaccine is currently approved for girls and boys, ages 9 through 26. The request by Merck to expand its market to women and men, ages 27 to 45, and the FDA's approval to grant it a Priority Review by October 6, 2018, follows 10 years after the FDA struck down a similar request to expand the older version of Gardasil to the same age group. Besides the hundreds of stories of young women being injured or even killed by the Gardasil vaccine, as well as the lawsuits mounting in countries outside the U.S., the published data regarding Gardasil just keeps getting worse. Will the FDA consider these studies in determining if Gardasil should be expanded to a larger population? Shouldn't the FDA instead be determining if Gardasil should even stay in the market, as other countries are beginning to ask?

Gardasil HPV Vaccine Acceptance into China Creates Instant Billionaires

Last month (May, 2018) we published a report from the vaccine marketing trade publication, Fierce Pharma, that Merck's sales this year were beating financial forecasts, primarily due to its entrance into the China market for its top-selling Gardasil HPV vaccine. Fierce Pharma reported at that time that the Gardasil vaccine was fast-tracked for approval into the China market: "Late last month, the Chinese FDA granted Gardasil 9 a conditional approval only nine days into a review." Now, Fierce Pharma is reporting that Gardasil's acceptance into the China market has produced instant billionaires.

Merck’s Fosamax Fraud Demonstrates How Big Pharma and CDC Spin Statistics to Sell Ineffective Vaccines and Drugs

It has been over a decade since I came to the realization that the entire profession of medicine had been bamboozled by the propaganda coming from the Big Pharma drug and vaccine maker, Merck & Company, that its so-called “fracture-preventative” drug Fosamax had defrauded us doctors and our patients by falsely claiming a “50% efficacy rate” in the prevention of bone fractures in osteopenic/osteoporotic women. By doing a little math, I understood that the honest truth of the matter was that patients who took the drug for four years had a miniscule 1-2% absolute risk reduction (AAR) in the incidence of fractures, which is a much more realistic figure that Merck, being a sociopathic entity that is inclined to tell half-truths or outright lies, chose not to use in its advertisements. It is a fact that being truthful in the drug or vaccine industry is an impediment to selling product, because they would be admitting they were selling a lousy, fraudulent, relatively ineffective or dangerous drug or vaccine. In other words, Big Pharma/BigVaccine is still successfully bamboozling us doctors and patients (as well as Big Media, the CDC, the FDA, the AMA, the AAP, the APA, the AAFP, the NIH, the NIMH, Wall Street and our politicians) with the old deceptive tactic of using relative risk reduction statistics about vaccine efficacy rather than honestly telling us the more truthful absolute risk reduction figures whenever they are rolling out their newest – and increasingly unaffordable – vaccines. Therefore, I devote the remainder of this column to reporting some excerpts from the internet and end with some examples of published studies from courageous researchers who have gone up against the drug industry and reported the important statistics that we should all demand to know when a vaccine (or drug) is being sold to us.

As Merck’s Gardasil U.S. Sales Decline Profits Continue to Increase as Vaccine is Launched in China

The pharmaceutical marketing trade publication, Fierce Pharma, announced this month (May 2018) that Merck has beat Wall Street expectations for their Gardasil vaccine sales during the first quarter of 2018, achieving 24% growth with $660 million for the HPV vaccine. The report notes that sales in the U.S. are declining, attributing the decline in sales to the CDC decision to reduce their recommendation of the Gardasil vaccine to be only two doses, instead of three. Nothing is mentioned about declining public opinion regarding Gardasil, nor the numerous lawsuits against the company outside the U.S. The increase in sales for Gardasil is attributed to their entrance into the China market. The original vaccine won Chinese approval last year, while late last month the Chinese FDA granted Gardasil 9 a conditional approval only nine days into a review.

Merck Fighting Fraud Lawsuits in U.S. Courts on MMR and Gardasil Vaccines

Pharmaceutical giant, Merck, is facing charges of fraud in lawsuits filed in U.S. courts regarding their vaccine products. This is important information for the public to know, given the fact that the ever-growing vaccine market is expected to exceed $70 billion within the next few years, and that many states are trying to pass legislation to mandate vaccines without informed consent, all in the name of "the greater good" for public health. Federal government agencies tasked with protecting public health, along with the corporate "mainstream" media, which reportedly receives up to 70% of its advertising revenue from pharmaceutical companies, continue to censor any negative information regarding vaccines that could affect sales. And since one cannot sue a pharmaceutical company for damages or deaths due to vaccines in the United States, where they enjoy legal immunity, it is rare that a pharmaceutical company faces a day in court related to corruption or fraud for bad vaccine products. Therefore, one needs to turn to either the alternative media such as Health Impact News, or the foreign media outside the U.S., to learn about the dangers of vaccines, and the corruption behind many of them. There are currently two major federal lawsuits against Merck that are being litigated in U.S. courts: a whistleblower lawsuit from former Merck scientists claiming fraud regarding the MMR vaccine, which has been in the courts for eight years now, and a lawsuit against the Gardasil vaccine claiming fraud from a 16-year-old girl who allegedly suffered Postural Orthostatic Tachycardia Syndrome (POTS) after receiving the Gardasil vaccine.

Man who worked for Senator Pan Paralyzed after Vaccine

People who have adverse reactions to vaccinations are marginalized, minimized and denied just compensation for their injuries. We take a look at the personal story of a man just injured from a vaccination, who had ironically worked for the California Senator who authored SB277 that removes parental informed consent for vaccinations. And a former drug rep for Merck who sold vaccines tells why he would never vaccinate his children.

Vaccine Whistleblowers File to Compel Merck to Respond to Federal Lawsuit

In a brief mention in the mainstream media that as far as we can tell only Reuters reported, former Merck vaccine scientists, who have become whistleblowers and have had a federal lawsuit pending against Merck since 2010 for vaccine fraud, have filed another court document in their case accusing Merck of withholding evidence and not complying with court orders.